Fabien Brocard

1.0k total citations
11 papers, 99 citations indexed

About

Fabien Brocard is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Fabien Brocard has authored 11 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Reproductive Medicine. Recurrent topics in Fabien Brocard's work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Fabien Brocard is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Fabien Brocard collaborates with scholars based in France, Italy and Germany. Fabien Brocard's co-authors include Schmutz Jl, F. Truchetet, Charles Cornet, P. Tréchot, François Alla, J.-F. Cuny, A. Barbaud, Anne Floquet, Frédèric Selle and Andreas Schnelzer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Oncologist.

In The Last Decade

Fabien Brocard

11 papers receiving 97 citations

Peers

Fabien Brocard

SURGE

ONCOL

PRM

PPCH

Burak Giray Türkiye

Elizabeth Ann Harris United States

Jessica Duran United States

Filomena Narducci Italy

J. Hartmann Germany

Alessandro Bruscino Italy

Carmelo Mazzeo Italy

Ho Sang Shon South Korea

Meer M. Chisthi India

Marie Claude Guertin Canada

Burak Giray Türkiye

Fabien Brocard

24 ×0.7

21 ×0.6

SURGE

13 ×0.4

ONCOL

3 ×0.1

PRM

8 ×0.6

PPCH

Citations per year, relative to Fabien Brocard Fabien Brocard (= 1×) peers Burak Giray

Countries citing papers authored by Fabien Brocard

Since Specialization

Citations

This map shows the geographic impact of Fabien Brocard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Brocard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Brocard more than expected).

Fields of papers citing papers by Fabien Brocard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Brocard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Brocard. The network helps show where Fabien Brocard may publish in the future.

Co-authorship network of co-authors of Fabien Brocard

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Brocard. A scholar is included among the top collaborators of Fabien Brocard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Brocard. Fabien Brocard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Zelek, Laurent, P. Debourdeau, Hugues Bourgeois, et al.. (2021). A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy. The Oncologist. 26(10). e1870–e1879. 12 indexed citations

Trédan, Olivier, Cyril Abdeddaim, Sylvie Chabaud, et al.. (2020). 829P Regorafenib (R) or tamoxifen (T) for platinum-sensitive recurrent ovarian cancer (PSROC) with rising CA125 and no evidence of clinical or radiological disease progression: A GINECO randomized phase II trial. Annals of Oncology. 31. S624–S625. 1 indexed citations

Hardy‐Bessard, Anne‐Claire, Fabien Brocard, Florian Clatot, et al.. (2020). First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study. The Breast. 54. 256–263. 8 indexed citations

Ray‐Coquard, Isabelle, Philipp Harter, Domenica Lorusso, et al.. (2020). Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors. JAMA Oncology. 6(12). 1923–1923. 33 indexed citations

Heudel, Pierre-Étienne, Antoine Arnaud, Jean‐Sébastien Frenel, et al.. (2019). A GINECO randomized phase II assessing addition of an aromatase inhibitor to oral vinorelbine in pretreated metastatic breast cancer patients.. Journal of Clinical Oncology. 37(15_suppl). 1043–1043. 1 indexed citations

Ray-Coquard, Isabelle Laure, Philipp Harter, Domenica Lorusso, et al.. (2018). Alienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse. Annals of Oncology. 29. viii333–viii333. 3 indexed citations

Salleron, Julia, María Rios, P. Nickers, et al.. (2017). A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas. Radiotherapy and Oncology. 125(1). 160–167. 7 indexed citations

Brocard, Fabien, Marianne Leheurteur, Jérôme Dauba, et al.. (2016). Phase II trial evaluating the combination of eribulin (E)+ bevacizumab (BEV) as first line chemotherapy in patients with metastatic Her2-negative breast cancer (MBC): a GINECO group study. Annals of Oncology. 27. vi72–vi72. 1 indexed citations

Bachet, Jean‐Baptiste, Olivier Lucidarme, Julien Taı̈eb, et al.. (2016). FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Results of the FFCD 1102 phase II trial.. Journal of Clinical Oncology. 34(15_suppl). 3513–3513. 3 indexed citations

10.

Lheureux, Stéphanie, et al.. (2012). Gestion des agents anticancéreux chez les insuffisants rénaux. Bulletin du Cancer. 99(3). 323–331. 4 indexed citations

11.

Cornet, Charles, P. Tréchot, François Alla, et al.. (2005). Study to determine the efficacy of topical morphine on painful chronic skin ulcers. Journal of Wound Care. 14(6). 289–293. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact